New brain zapping method could ease PTSD in just 5 days
NCT ID NCT07463703
First seen Jun 27, 2026 · Last updated Jul 29, 2026 · Updated 2 times
Summary
This study tests a new, quick brain stimulation treatment for PTSD. Fifteen adults with PTSD will get a brain scan to map their fear and control centers. Then, over 5 days, they receive many short magnetic pulses to strengthen brain connections and reduce symptoms. The study checks if this approach is safe, practical, and shows early signs of helping.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 15 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Aug 2026
An estimate. Start dates often move.
- Expected to finish
-
Jan 2027
An estimate. End dates often move.
- Lead sponsor
-
A company
The lead sponsor is a pharmaceutical, biotech, or medical-device company.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria Participants must meet ALL of the following criteria: 1. Age 18-65 years (inclusive) 2. DSM-5 diagnosis of PTSD confirmed by Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) 3. PCL-5 total score ≥33 (indicating at least moderate symptom severity) 4. PTSD symptom duration ≥3 months 5. If taking psychotropic medications, stable dose for ≥6 weeks prior to enrollment with no planned changes during study participation 6. Able to provide written informed consent 7. English-speaking (required for validated assessment measures) 8. Able to attend daily treatment sessions for 5 consecutive weekdays 9. Eligible for 1.5T MRI scanning (no contraindications) Exclusion Criteria Participants meeting ANY of the following criteria will be excluded: TMS Contraindications: 1. Conductive, ferromagnetic, or other magnetic-sensitive metals implanted in the head or within 30 cm of the TMS coil (excluding the mouth), including: * Cochlear implants * Deep brain stimulators * Vagus nerve stimulators * Aneurysm clips or coils * Stents in the neck or brain * Electrodes * Any implanted electronic devices 2. History of seizure disorder (excluding single childhood febrile seizure) 3. First-degree family member with epilepsy 4. History of significant head trauma with loss of consciousness \>10 minutes 5. History of stroke, brain tumor, or other neurological disorder 6. Neurosurgical procedures involving brain tissue MRI Contraindications: 1. Implanted medical devices incompatible with MRI 2. Claustrophobia preventing MRI scan completion 3. Body size preventing MRI scanner entry Psychiatric Exclusions: 1. Lifetime history of psychotic disorder (schizophrenia, schizoaffective disorder, delusional disorder) 2. Lifetime history of bipolar I disorder 3. Current (within past month) moderate or severe substance use disorder per DSM-5 criteria 4. Current active suicidal ideation with intent or plan (Columbia Suicide Severity Rating Scale score ≥4) 5. Psychiatric hospitalization within past 3 months Medical Exclusions: 6. Unstable medical condition that, in the investigator's judgment, would interfere with study participation or pose safety risk 7. Pregnancy or breastfeeding (females of childbearing potential must have negative urine pregnancy test at screening) 8. Prior TMS treatment within past 3 months 9. Current participation in another interventional research study 10. Initiation of psychotherapy specifically for PTSD within past 3 months (stable ongoing therapy is permitted)
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PTSD - post traumatic stress disorder are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Cognitive FX TMS Clinic
RECRUITINGProvo, Utah, 84604, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a sedative plus ear stimulation stop PTSD before it starts?
- Can a single day of brain stimulation plus a drug ease PTSD?
- One-Day brain zaps plus antibiotic could rewire PTSD in first responders
- Virtual reality could open doors to trauma therapy
- Faith-Based therapy aims to heal trauma in young women
- Could play be a lifeline for children of war? a major study investigates